[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![RJResearch Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055892935038984192.png) Raymond James Equity Research [@RJResearch](/creator/twitter/RJResearch) on x 1615 followers
Created: 2025-07-02 14:05:16 UTC

Gary Nachman published, "BioPharma|Key Insights From KOL Call on Several Areas of Interest in Immunology, Allergy, and Asthma" following his investor call with a high-volume Allergist-Immunologist, with takeaways for $ADMA $IONS $AQST $EPRX and $AMGN


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1940411455989280885/c:line.svg)

**Related Topics**
[amgn](/topic/amgn)
[$eprx](/topic/$eprx)
[$aqst](/topic/$aqst)
[investment](/topic/investment)
[kol](/topic/kol)
[$adma](/topic/$adma)
[$ions](/topic/$ions)
[$amgn](/topic/$amgn)

[Post Link](https://x.com/RJResearch/status/1940411455989280885)